ライフサイエンスコーパス: nonsudden

1 In 37 cardiac deaths (18 nonsudden, 19 sudden), stored EGMs were present within 1

2 Of the cardiac deaths, 55 (66%) were nonsudden and 28 (34%) were sudden.

3 There were 811 CHD deaths: 453 nonsudden and 358 SCDs.

4 calculate the odds ratio (OR), compared with nonsudden and other coronary deaths, for sudden coronary

5 ardial infarctions (196 were sudden, 94 were nonsudden, and 3 were not classifiable).

6 e examined to assess death rates for sudden, nonsudden, and other coronary deaths.

7 Compared with the nonsudden cardiac and noncardiac categories, sudden card

8 oward greater treatment effect was noted for nonsudden cardiac death (OR 0.58, 95% CI 0.40 to 0.83) c

9 are at increased risk for heart failure and nonsudden cardiac death after device termination of VT o

10 h a high frequency of heart failure and late nonsudden cardiac death after first successful ICD thera

11 erence was primarily due to a higher rate of nonsudden cardiac death in Group 1.

12 n survival is attenuated by the high rate of nonsudden cardiac death in those treated.

13 In contrast, nonsudden cardiac death was associated with a higher res

14 Nonsudden cardiac death was treated as a competing event

15 s cardiovascular events including sudden and nonsudden cardiac death, fatal and nonfatal myocardial i

16 reduced risk of total myocardial infarction, nonsudden cardiac death, or total cardiovascular mortali

17 to those at the greatest risk of sudden and nonsudden cardiac death.

18 decreases all-cause mortality and sudden and nonsudden cardiac death.

19 diac defibrillators, which have no impact on nonsudden cardiac death.

20 were, among the 162 patients, a total of two nonsudden cardiac deaths-one 71 days and the other 157 d

21 or ventricular tachycardia >240 bpm) and 36 nonsudden cardiac deaths.

22 h group (53% vs. 20%, p = 0.05), whereas the nonsudden cardiac event group had a significantly higher

23 There were 14 deaths (10 nonsudden cardiac, 3 sudden cardiac, 1 noncardiac).

24 hs into accepted categories: sudden cardiac, nonsudden cardiac, and noncardiac.

25 scular death (HR, 0.62 [95% CI, 0.46-0.84]), nonsudden cardiovascular death (HR, 0.59 [95% CI, 0.42-0

26 ed left ventricular ejection fraction die of nonsudden causes of death.

27 also have low competing risks of death from nonsudden causes.

28 Nonsudden CHD death decreased by 64% (95% CI 50% to 74%,

29 We examined temporal trends in SCD and nonsudden CHD death in the Framingham Heart Study origin

30 rast, the relationship of alcohol intake and nonsudden CHD death was L-shaped or linear (P for trend=

31 Ninety-one (20%) of nonsudden CHD deaths and 173 (48%) of SCDs were in subje

32 The risks of SCD and nonsudden CHD mortality have decreased by 49% to 64% ove

33 ), those dying without such sudden symptoms (nonsudden coronary death), and those with unknown durati

34 e smoking more likely results in sudden than nonsudden coronary death, perhaps because of nicotine-in

35 Sudden coronary deaths were less likely than nonsudden coronary deaths to occur at home (OR = 0.5, 95

36 se distinguished sudden coronary deaths from nonsudden coronary deaths.

37 h were divided into sudden cardiac death and nonsudden death and compared between patients younger an

38 In the nonsudden death cohort, 19.5% displayed a significant cl

39 cise to the overall risk of sudden death and nonsudden death from coronary heart disease was assessed

40 d for by the relation of fish consumption to nonsudden death from myocardial infarction (relative ris

41 eath from coronary heart disease, especially nonsudden death from myocardial infarction.

42 iac death rate was 1.8 (95% CI, 1.3-2.5) and nonsudden death rate was 2.7 (95% CI, 2.1-3.5) events pe

43 iac death rate was 1.6 (95% CI, 0.8-3.2) and nonsudden death rate was 5.4 (95% CI, 3.7-7.8) events pe

44 40% at increased risk of SCD and low risk of nonsudden death who may benefit from implantable cardiov

45 articularly in patients at competing risk of nonsudden death.

46 re noted when comparing sudden deaths versus nonsudden deaths (p < 0.001), defibrillators versus pace

47 ressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from

48 There were two nonsudden deaths in the concurrent control subjects (n =

49 Nonsudden deaths were studied.

50 jority of sudden deaths and in almost 20% of nonsudden deaths.

51 rogeneity, together with the observation of "nonsudden jump" FRET transitions, indicates that the ear

52 om coronary heart disease and from sudden or nonsudden myocardial infarction were 0.62 (95 percent co

53 death in HCM occurs suddenly (SCD) or may be nonsudden (non-SCD).

54 iac or unknown); 2) temporal course (sudden, nonsudden or unknown); 3) documentation (witnessed, moni

55 death from myocardial infarction (sudden or nonsudden) or death from other coronary causes.

56 ary deaths in the home are more likely to be nonsudden than sudden.